Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Articles by Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Latest Updated Articles
Rapid Readouts: Phase 1/2 KRYSTAL-1 TrialNovember 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
5